Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,440.00    -50.00 (-3.36%)
Bid:
1,434.00
Ask:
1,442.00
Spread: 8.00 (0.558%)
Market Cap: £493.01m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Form 8.3 - Craneware Plc

19 May 2025 13:43

RNS Number : 2547J
Aegon Ltd
19 May 2025
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Aegon Ltd.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Craneware plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

16/05/2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

 

Class of relevant security:

 

1p ordinary

 

 

Interests

 

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,829,762.00

5.17

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

1,829,762.00

5.17

 

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

19/05/2025

Contact name:

Anne Schotte

Telephone number:

+31 620812957

 

For any issue relating to this disclosure please contact

 

substshareholding@aegon.com

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETSFEFEUEISELI
Date   Source Headline
23rd Sep 20229:06 amRNSVesting of Long Term Incentive Plan Awards
21st Sep 20224:14 pmRNSExercise of Share Options
20th Sep 20227:00 amRNSFinal Results
14th Sep 20223:29 pmRNSChange of Date of Final Results
26th Jul 20227:00 amRNSFY22 Trading Update and Notice of Results
7th Jul 20226:13 pmRNSHolding(s) in Company
27th Apr 20221:00 pmRNSBoard Appointment
14th Apr 202212:35 pmRNSBlock listing Interim Review
31st Mar 20224:09 pmRNSTotal Voting Rights
25th Mar 20222:16 pmRNSDividend Currency Election
22nd Mar 20221:37 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSDividend Payment Date Update
14th Mar 20227:00 amRNSInterim Results
7th Mar 20225:20 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSBlocklisting Application
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSTrading Update and Notice of Results
26th Nov 20215:05 pmRNSDividend Currency Election
19th Nov 20212:46 pmRNSGrant of Long Term Incentive Plan Awards
16th Nov 20212:09 pmRNSResult of AGM
16th Nov 20217:00 amRNSAGM Statement and Integration Update
19th Oct 20217:00 amRNSPosting of Annual Report and Notice of AGM
15th Oct 20213:37 pmRNSBlock listing Interim Review
22nd Sep 202112:52 pmRNSPurchase of Shares
21st Sep 20215:58 pmRNSDividend Timetable
21st Sep 20217:00 amRNSFinal Results
20th Jul 20214:53 pmRNSHolding(s) in Company
14th Jul 20215:19 pmRNSHolding(s) in Company
13th Jul 20217:00 amRNSCompletion of SDS Holdco, Inc. Acquisition
13th Jul 20217:00 amRNSTrading Update and Notice of Results
18th Jun 202111:42 amRNSHolding(s) in Company
14th Jun 202110:01 amRNSHolding(s) in Company
10th Jun 202111:55 amRNSHolding(s) in Company
10th Jun 202111:53 amRNSDirector/PDMR Share Dealings
8th Jun 20214:40 pmRNSSecond Price Monitoring Extn
8th Jun 20214:35 pmRNSPrice Monitoring Extension
8th Jun 20212:05 pmRNSSecond Price Monitoring Extn
8th Jun 20212:00 pmRNSPrice Monitoring Extension
8th Jun 202111:05 amRNSSecond Price Monitoring Extn
8th Jun 202111:00 amRNSPrice Monitoring Extension
8th Jun 20219:05 amRNSSecond Price Monitoring Extn
8th Jun 20219:00 amRNSPrice Monitoring Extension
8th Jun 20217:00 amRNSResults of Placing and Total Voting Rights
7th Jun 20215:27 pmRNSProposed Placing
7th Jun 20215:25 pmRNSAcquisition of SDS Holdco, Inc.
15th Apr 20217:00 amRNSBlock listing Interim Review
19th Mar 20211:05 pmRNSDividend Currency Election
1st Mar 20217:00 amRNSInterim Results
20th Jan 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.